Healthcare Services

Global Genital Warts Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Genital Warts Market At The End Of The 2026–2030 Forecast Period?

The market for genital warts has shown significant growth in recent years. It is projected to expand from $2.06 billion in 2025 to $2.17 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.1%. Historically, this growth can be attributed to the high prevalence of HPV infections, the availability of topical drugs, the early adoption of ablative procedures, various sexual health awareness programs, and established clinical treatment guidelines.

The genital warts market size is anticipated to undergo significant expansion over the coming years. It is projected to achieve a value of $2.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. This expected growth throughout the forecast period stems from factors such as enhanced hpv vaccination coverage, the introduction of new topical agents, an increase in outpatient treatment options, proactive early screening efforts, and a patient preference for non-invasive care. Key trends anticipated during the forecast period include a greater embrace of topical treatment therapies, heightened awareness regarding hpv-related infections, an escalating demand for minimally invasive ablative treatments, the broader implementation of preventive hpv vaccination programs, and an increased utilization of home-based treatment solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Genital Warts Market?

The rising incidence of sexually transmitted infections (STIs) is a key factor driving the expansion of the genital warts market in the future. STIs are defined as infections predominantly spread via sexual activities like vaginal, anal, and oral intercourse, stemming from bacterial, viral, or parasitic origins. The growing frequency of sexually transmitted infections is attributed to factors such as higher levels of sexual engagement, insufficient use of protective measures, and restricted availability of educational and health resources. Genital warts, a widespread sexually transmitted infection (STI), are specifically caused by certain types of human papillomavirus (HPV). Their transmission occurs via direct skin-to-skin contact during sexual encounters. For example, in September 2025, the Centers for Disease Control and Prevention, a US government public health body, stated that over 2.2 million instances of chlamydia, gonorrhea, and syphilis were documented in 2024. Consequently, the expanding occurrence of sexually transmitted infections (STIs) fuels the expansion of the genital warts market.

What Segment Types Make Up The Genital Warts Market?

The genital warts market covered in this report is segmented –

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid

2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments

3) By Gender: Female, Male

4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegments:

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

Which Trends Are Impacting The Growth Of The Genital Warts Market?

Major companies in the genital warts market are developing new treatment options, such as innovative dermatology drugs, to address the challenges faced by patients with genital warts. Dermatology drugs refer to recently developed pharmaceuticals or therapeutic agents specifically designed to treat various dermatologic conditions, including genital warts. For example, in March 2023, Verrica Pharmaceuticals Inc., a US-based dermatology pharmaceutical company, received New Chemical Entity (NCE) status for its drug candidate YCANTH. YCANTH is being developed to treat genital warts and has completed phase 2 trials. With FDA NCE status, the company now benefits from at least five years of protection from generic competition.

Who Are The Key Players Driving Competition In The Genital Warts Market?

Major companies operating in the genital warts market are Merck & Co. Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, ANI Pharmaceuticals Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ Global AB, Cassiopea Inc, GlaxoSmithKline plc, Pfizer Inc, Bayer AG, Astellas Pharma Inc, Amgen Inc, Boehringer Ingelheim, Johnson & Johnson, Eli Lilly and Company, Novan Inc

Read the full genital warts market report here:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Which Regions Are Projected To Dominate The Genital Warts Market In The Coming Years?

North America was the largest region in the genital warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Genital Warts Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

Browse Through More Reports Similar to the Global Genital Warts Market 2026, By The Business Research Company

Genital Warts Global Market Report

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Sexually Transmitted Infections Stis Global Market Report

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Herpes Simplex Virus Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/herpes-simplex-virus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795